ACTIBLOK-IPR

Product Description

Biocon offers a wide range of metabolic which includes actiblok-ipr. Composition: metoprolol extended release 25/50/100mg tablets. Mechanism of action: metoprolol is a beta 1-selective (cardioselective) adrenergic receptor blocking agent. It competitively antagonizes catecholamines at peripheral (especially cardiac) adrenergic neuron sites, leading to decreased cardiac output. Indications: hypertension, angina/ihd, myocardial infarction in patients with hypertension, heart failure

Biocon Limited

  • IN
  • 2015
    On CPhI since
Contract Service
Manufacturer/Innovator
Specifications
  • Selling Points
    Experienced Technicians; International Approvals/Standards; Quality Service
  • Supplied from
    India

Biocon Limited

  • IN
  • 2015
    On CPhI since
Contract Service
Manufacturer/Innovator

More Products from Biocon Limited

  • ACTIBLOK AM

    Product ACTIBLOK AM

    Biocon offers a wide range of metabolic which includes actiblok am. Composition: metoprolol succinate 25/50 mg and amlodipine 5 mg tablets. Mechanism of action: metoprolol is a beta1-selective (cardioselective) adrenergic receptor blocking agent, amlodipine: amlodipine is a dihydropyridine calcium channel blocker, which inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle. Indications: uncontrolled hypertension, stable angina and silent ischemic patients
  • Advacan

    Product Advacan

    Biocon offers a wide range of nephrology which includes advacan. Composition: each uncoated /coated tablet contains everolimus 0.5mg and 0.25mg. Mechanism of action: everolimus, a proliferation signal inhibitor, prevents allograft rejection in allotransplantation. It exerts its immunosuppressive effect by inhibiting the proliferation, and thus clonal expansion, of antigen-activated t cells which is driven by t cell-specific interleukins, e.g. Interleukin-2 and interleukin-15. Indications: it is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk, receiving an allogeneic renal or cardiac transplant. Advacan should be used in combination with cyclosporine and corticosteroids

Biocon Limited resources

Recommended products